LOS ANGELES, Nov. 26, 2024 (GLOBE NEWSWIRE) -- via IBN – Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics, has selected IBN, a multifaceted financial news and publishing company for private and public entities, to spearhead its corporate communications efforts. Kairos Pharma’s development pipeline targets drug resistance and immune suppression, two critical barriers to effective cancer treatment. The company's flagship ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores a ...

It's been a relatively challenging results season for Indian corporates, but the country's second-largest banking group, ICICI Bank (NYSE: IBN ), lived up to its 'all-weather' billing once again (see ICICI Bank: Weathering The Cycles With India's 'All Weather' BankingAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinio ...

ICICI Bank Ltd.'s (IBN) net income for the second quarter of fiscal 2025 (ended Sept. 30, 2024) was INR 117.5 billion ($1.4 billion), up 14.5% from the prior-year quarter. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. Results were driven by a rise in net interest income (NII), non-interest income, and growth in loans and deposits. However, higher operating expenses and provisions were the undermining factors. IBN's NII & Fee Income Improve, Expenses Rise NII grew 9.5% year over y ...

Company Overview - Brera Holdings PLC is a publicly traded multi-club ownership company focused on football, headquartered in Ireland [1][2] - The company aims to expand its global portfolio of men's and women's sports clubs through a unique multi-club ownership strategy [1][3] - Brera Holdings seeks to unlock value from underutilized sports clubs and talent through various revenue streams, including tournament prizes, sponsorship deals, transfer fees, and professional sports consulting [1][3] Strategic Focus - The company builds on the legacy of Brera FC, an Italian soccer club known for its social impact and contributions to society [2] - Brera Holdings targets top-division teams in emerging markets across Africa, Asia, and Europe to acquire undiscovered talent and enhance its competitive edge in tournaments [2] - The company emphasizes delivering socially impactful outcomes for its players and fans [1][2] Corporate Communications - Brera Holdings has selected IBN to lead its corporate communications efforts, leveraging IBN's extensive distribution network to increase awareness [3] - IBN has over 18 years of experience and a collective audience of millions, positioning it to effectively reach investors, journalists, and the general public [3][4] - The partnership aims to enhance Brera Holdings' visibility and engagement with various stakeholders [3][5]

LOS ANGELES, Oct. 03, 2024 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The MiningNewsWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The MiningNewsWire Podcast features revealing sit-downs with executives who are shaping the future of the global mining industry. The late ...

LOS ANGELES, Sept. 09, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The MiningNewsWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The MiningNewsWire Podcast features revealing sit-downs with executives who are shaping the future of the global mining industry. The late ...

Core Insights - The latest episode of The BioMedWire Podcast features Amir Reichman, CEO of Scinai Immunotherapeutics Ltd., discussing the company's innovative approach in the biopharmaceutical sector [2][3] - Scinai Immunotherapeutics is focused on developing biological therapeutic products targeting inflammation and immunology, utilizing a unique technology of VHH single domain antibodies derived from alpacas [3][5] - The company employs a de-risking strategy by targeting molecular areas already explored by other manufacturers, aiming to address significant unmet medical needs in patient populations [3] Company Overview - Scinai Immunotherapeutics Ltd. operates two business units: one dedicated to the development of biological therapeutic products and the other providing CDMO services for early-stage biotech projects [5] - The company’s innovative pipeline includes nanosized VHH antibodies (NanoAbs) designed to target diseases with large unmet medical needs [5] Podcast and Distribution - The BioMedWire Podcast aims to connect public companies with the investment community through specialized content distribution [1][4] - IBN has over 18 years of experience in providing corporate messaging solutions to more than 500 public and private companies, leveraging a robust network of brands and followers [4][6]

LOS ANGELES, Sept. 03, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. The latest ...